Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(7):485; doi:10.1093/jnci/93.7.485
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 7, 485, April 4, 2001
© 2001 Oxford University Press

IN THIS ISSUE

Effects of Retinoids on Ovarian Cancer Cells

Retinoids are one of the most promising groups of chemopreventive agents, and they have shown evidence in clinical trials of their benefit in preventing recurrence of breast cancer and first occurrence of ovarian cancer. Because of a need to identify retinoids that are effective at clinically achievable doses, Guruswamy et al. (p. 516) studied the effects of a variety of retinoids and related compounds, including some novel compounds, on ovarian cancer cells in culture. They found that all 11 compounds tested . . . [Full Text of this Article]

Modeling Bone Metastasis

Gender and Smoking-Related Bladder Cancer Risk

Patient Treatment and Outcome by Provider Characteristics

Diet and Colorectal Cancer Risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?